New modified release Composition and use

摘要

A Pharmaceutical composition comprising an anti hyperglycaemic Agent and another Antidiabetic Agent and a pharmaceutically acceptable Vehicle thereforThe composition, willing to provide a sustained release of at least one of the two agents.A Pharmaceutical composition according to claim 1,In which the anti hyperglycaemic Agent as a Thiazolidinedione, Insulin sensitizer is as 5 - [4 - [2 - (n-methyl-n - (2-pyridyl) amino) ethoxy] benzyl] tiazolidina - 24 - dione and another Antidiabetic Agent and a pharmaceutically acceptable vehicle for the sameIn which the vehicle is arranged to provide a modified release of at least the insulin sensitizer and another Antidiabetic Agent.